6 employees
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
2020
$3.2M
from 2 investors over 2 rounds
Prolocor raised $3.2M on August 16, 2022
Investors: Labcorp and Green Park & Golf Ventures